VAERS reports by lot

GSK Varicella/Shingles lot MP42R: VAERS reports

53 VAERS reports list lot MP42R as a GSK Varicella/Shingles vaccine, received between 2019-05-31 and 2020-02-21. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
53
Reports
2%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5825%
Injection-site / Local reaction5725%
Dermatological (non-injection-site)2611%
Neurological219%
Musculoskeletal219%
Gastrointestinal188%
Allergic / Anaphylactic136%
Respiratory63%
Cardiac / Cardiovascular52%
Psychiatric / Neuropsychiatric21%
Thrombotic / Hematological10%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
New Jersey5
California5
Massachusetts4
Indiana4
Idaho4
North Carolina3
Missouri3
Washington3
Pennsylvania2
Georgia2
Michigan2
Hawaii2

Reports by month received

MonthReportsBar
2019-051
2019-0627
2019-079
2019-085
2019-093
2019-101
2019-114
2020-011
2020-022

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK Varicella/Shingles lots (A–Z): MG5S9 · MJ5B5 · ML532 · MT7C9 · MX2LT · MY2B2

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.